Current Urology Reports

, 15:387

Role of Multiparametric Magnetic Resonance Imaging in the Diagnosis of Prostate Cancer

  • Soroush Rais-Bahrami
  • Baris Turkbey
  • Kinzya B. Grant
  • Peter A. Pinto
  • Peter L. Choyke
New Imaging Techniques (A Atala and A Rastinehad, Section Editors)

DOI: 10.1007/s11934-013-0387-9

Cite this article as:
Rais-Bahrami, S., Turkbey, B., Grant, K.B. et al. Curr Urol Rep (2014) 15: 387. doi:10.1007/s11934-013-0387-9
Part of the following topical collections:
  1. Topical Collection on New Imaging Techniques


Prostate cancer is the most common solid-organ malignancy among American men. It is currently most commonly diagnosed on random systematic biopsies prompted by elevated serum PSA levels. Multi-parametric MRI (MP-MRI) of the prostate has emerged as an anatomic and functional imaging modality, which offers accurate detection, localization and staging of prostate cancer. Recently, MP-MRI has gained an increasing role in guiding biopsies to sites of abnormality and in monitoring patients on active surveillance. Here, we discuss the historical development, current role, and potential future directions of MP-MRI in the diagnosis of prostate cancer.


Cancer DetectionMagnetic Resonance ImagingProstate BiopsyCancer Imaging



Biopsy Gleason Score


Biparametric MRI


Diffusion Weighted Imaging


Digital Rectal Examination


Magnetic Resonance Imaging


Magnetic Resonance/Ultrasound


Multiparametric MRI


Negative Predictive Value


Positive Predictive Value


Prostate Cancer


Prostate Specific Antigen


PSA Density


Screen Positive Lesions


T2 Weighted

Copyright information

© Springer Science+Business Media New York (outside the USA) 2014

Authors and Affiliations

  • Soroush Rais-Bahrami
    • 1
  • Baris Turkbey
    • 2
  • Kinzya B. Grant
    • 2
  • Peter A. Pinto
    • 1
    • 3
  • Peter L. Choyke
    • 2
  1. 1.Urologic Oncology BranchNational Cancer Institute, National Institutes of HealthBethesdaUSA
  2. 2.Molecular Imaging ProgramNational Cancer Institute, National Institutes of HealthBethesdaUSA
  3. 3.Center for Interventional OncologyNational Cancer Institute, National Institutes of HealthBethesdaUSA